Bristol-Myers Squibb Launches an Online Resource for Patients with Chronic Myeloid Leukaemia in 15 European Countries

Bristol-Myers Squibb Launches an Online Resource for Patients with Chronic Myeloid Leukaemia in 15 European Countries PR Newswire PARIS, December 7, 2012 PARIS, December 7, 2012 /PRNewswire/ -- My CML Life Online Resource Centre Empowers and Guides Patients with CML Through Different Stages of Their Journey Bristol-Myers Squibb Company (NYSE:BMY) today announced the introduction of "My CML Life", a disease awareness website for patients with chronic myeloid leukaemia (CML). In recognition of the need to raise awareness of this rare cancer, Bristol-Myers Squibb launched the "My CML Life" website to provide patients in Europe with easy-to- understand medical information and tools that offer support through various stages of their journey with CML. "We are excited to bring this resource to patients and their caregivers in Europe," said Estelle Vester-Blockland, Executive Medical Director Oncology for Bristol-Myers Squibb. "Bristol-Myers Squibb will be providing this resource to patients in 15 countries across Europe, offering them support to manage and cope with their disease, and empower them to have a more informed dialogue with their doctor". The educational content featured on the "My CML Life" website was developed by Bristol-Myers Squibb in close consultation with their advisory committee.